Both in Pharmaceuticals
OS Therapies Incorporated vs iBio
Over the past year OSTX returned −19.9% and IBIO returned +39.9%; their daily moves had a correlation of 0.22.
OSTX −19.9% IBIO +39.9%Growth of $1, one year, split-adjusted
| Metric | OSTX | IBIO |
|---|---|---|
| Price | $1.61 | $1.17 |
| Market cap | $75.4M | $75.2M |
| Today | −2.42% | 0.00% |
| 1 month | −1.8% | −14.0% |
| 6 months | +21.1% | −31.6% |
| Year to date | +15.0% | −39.4% |
| 1 year | −21.5% | +44.3% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 752.4× |
| Net cash | $105.0K | $88.0M |
| Dividend yield | — | — |
| Volatility (60d) | 65.6% | 44.1% |
| Short % of float | 5.2% | 8.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).